Literature DB >> 4357508

Restricted replication of vesicular stomatitis virus in human lymphoblastoid cells.

M Nowakowski, B R Bloom, E Ehrenfeld, D F Summers.   

Abstract

Replication of vesicular stomatitis virus (VSV) is restricted in one human lymphoblastoid cell line (Raji), but not in another similar cell line (Wil-2), compared with growth in HeLa cells. This restriction is characterized by a low proportion of cells yielding infectious virus and is associated with limited production of 42S virion RNA. Primary transcription of 13S and 26S VSV-specific RNA is not restricted in Raji cells, and the 13S RNA produced contains adenylate-rich sequences. This suggests that the block in Raji cells involves some step required for the replication of virion RNA.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4357508      PMCID: PMC356768     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  17 in total

1.  Mengovirus RNA synthesis in productive and restrictive cell lines.

Authors:  R Wall; M W Taylor
Journal:  Virology       Date:  1970-09       Impact factor: 3.616

2.  Formation of viral ribonucleic acid and virus in cells that are permissive or nonpermissive for murine encephalomyelitis virus (GDVII).

Authors:  L S Sturman; I Tamm
Journal:  J Virol       Date:  1969-01       Impact factor: 5.103

3.  Susceptibility of human lymphoblasts (RPMI 7466) to viral infections in vitro.

Authors:  R E Wallace
Journal:  Proc Soc Exp Biol Med       Date:  1969-03

4.  Autogenous and virus-induced interferons from lines of lymphoblastoid cells.

Authors:  B A Zajac; W Henle; G Henle
Journal:  Cancer Res       Date:  1969-08       Impact factor: 12.701

5.  Morphological and virological investigations on cultured Burkitt tumor lymphoblasts (strain Raji).

Authors:  M A Epstein; B G Achong; Y M Barr; B Zajac; G Henle; W Henle
Journal:  J Natl Cancer Inst       Date:  1966-10       Impact factor: 13.506

6.  Human lymphoblastoid lines from lymph node and spleen.

Authors:  J A Levy; M Virolainen; V Defendi
Journal:  Cancer       Date:  1968-09       Impact factor: 6.860

7.  Specific role of each human leukocyte type in viral infections. 3. 17D yellow fever virus replication and interferon production in homogeneous leukocyte cultures treated with phytohemagglutinin.

Authors:  E F Wheelock; R Edelman
Journal:  J Immunol       Date:  1969-09       Impact factor: 5.422

8.  Vaccinia virus replication and cytopathic effect in cultures in phytohemagglutinin-treated human peripheral blood leukocytes.

Authors:  G Miller; J F Enders
Journal:  J Virol       Date:  1968-08       Impact factor: 5.103

9.  Specific role of each human leukocyte type in viral infections. II. Phytohemagglutinin-treated lymphocytes as host cells for vesicular stomatitis virus replication in vitro.

Authors:  R Edelman; E F Wheelock
Journal:  J Virol       Date:  1968-05       Impact factor: 5.103

10.  On the number and nature of antigen-sensitive lymphocytes in the blood of delayed-hypersensitive human donors.

Authors:  L Jimenez; B R Bloom; M R Blume; H F Oettgen
Journal:  J Exp Med       Date:  1971-04-01       Impact factor: 14.307

View more
  10 in total

1.  Phosphorylation of specific serine residues within the acidic domain of the phosphoprotein of vesicular stomatitis virus regulates transcription in vitro.

Authors:  A M Takacs; S Barik; T Das; A K Banerjee
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

2.  Abortive infection of a rabbit cornea cell line by vesicular stomatitis virus: conversion to productive infection by superinfection with vaccinia virus.

Authors:  H R Thacore; J S Youngner
Journal:  J Virol       Date:  1975-08       Impact factor: 5.103

3.  Virus-lymphocyte interactions: inductive signals necessary to render B lymphocytes susceptible to vesicular stomatitis virus infection.

Authors:  M R Schmidt; R T Woodland
Journal:  J Virol       Date:  1990-07       Impact factor: 5.103

4.  Stimulation of vesicular stomatitis virus in vitro RNA synthesis by microtubule-associated proteins.

Authors:  V M Hill; S A Harmon; D F Summers
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

5.  Replicative RNA synthesis and nucleocapsid assembly in vesicular stomatitis virus-infected permeable cells.

Authors:  J H Condra; R A Lazzarini
Journal:  J Virol       Date:  1980-12       Impact factor: 5.103

6.  Persistence of vesicular stomatitis virus in cloned interleukin-2-dependent natural killer cell lines.

Authors:  K L Rosenthal; R M Zinkernagel; H Hengartner; P Groscurth; G Dennert; D Takayesu; L Prevec
Journal:  J Virol       Date:  1986-11       Impact factor: 5.103

7.  Growth restriction of negative-strand-RNA viruses in a rat 3Y1 cell line.

Authors:  H Saso; K Shimokata; T Toyoda; B Gotoh; Y Nagai
Journal:  Med Microbiol Immunol       Date:  1990       Impact factor: 3.402

8.  Sequential phosphorylation of the phosphoprotein of vesicular stomatitis virus by cellular and viral protein kinases is essential for transcription activation.

Authors:  S Barik; A K Banerjee
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

9.  Activation of measles virus from silently infected human lymphocytes.

Authors:  C J Lucas; J C Ubels-Postma; A Rezee; J M Galama
Journal:  J Exp Med       Date:  1978-10-01       Impact factor: 14.307

10.  Replication of vesicular stomatitis virus in murine spleen cells: enrichment of the virus-replicating lymphocytes and analysis of replication restriction.

Authors:  D R Webb; S Munshi; A K Banerjee
Journal:  Infect Immun       Date:  1981-04       Impact factor: 3.441

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.